Lymphatic Distribution of Etanercept Following Intravenous and Subcutaneous Delivery to Rats
Authors:
- 27 July 2020
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 37 (8) , 1-8
Abstract
Purpose The purpose of this work was to investigate the role of the lymphatic system in the pharmacokinetics of etanercept, a fusion protein. Methods Etanercept 1 mg/kg was administered intravenously (IV) and subcutaneously (SC) to thoracic lymph duct-cannulated and sham-operated control rats. Blood and lymph samples were obtained for up to 6 days. Results Model-based SC bioavailability of etanercept was 65.2% in the control group. In lymph-cannulated rats, etanercept concentration in the lymph was consistently lower than in serum following IV dosing; and the concentration in the lymph was significantly higher than in serum after SC injection. The absorption occurred predominantly through the lymphatic pathway (82.7%), and only 17.3% by direct uptake into the central compartment (blood pathway). Lymphatic cannulation reduced the area under the serum concentration-time curve by 28% in IV group and by 91% in SC group. A mechanistic pharmacokinetic model that combined dual absorption pathways with redistribution of the systemically available protein drug into lymph was developed. The model successfully captured serum and lymph data in all groups simultaneously, and all parameters were estimated with sufficient precision. Conclusions Lymphatic system was shown to play an essential role in systemic disposition and SC absorption of etanercept.Keywords
Funding Information
- Bristol Myers Squibb Foundation
This publication has 20 references indexed in Scilit:
- Mechanisms of Subcutaneous Absorption of Rituximab in RatsDrug Metabolism and Disposition, 2013
- Subcutaneous Absorption of Monoclonal Antibodies: Role of Dose, Site of Injection, and Injection Volume on Rituximab Pharmacokinetics in RatsPharmaceutical Research, 2011
- Pharmacokinetic-pharmacodynamic disease progression model for effect of etanercept in Lewis rats with collagen-induced arthritis.Pharmaceutical Research, 2011
- Lymphatic Absorption of Subcutaneously Administered Proteins: Influence of Different Injection Sites on the Absorption of Darbepoetin Alfa Using a Sheep ModelDrug Metabolism and Disposition, 2007
- The role of the lymphatic system in subcutaneous absorption of macromolecules in the rat modelEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- Collection of lymph-borne dendritic cells in the ratNature Protocols, 2006
- Lymphatic Absorption Is the Primary Contributor to the Systemic Availability of Epoetin Alfa following Subcutaneous Administration to SheepThe Journal of Pharmacology and Experimental Therapeutics, 2005
- TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseasesNature Medicine, 2003
- One technique, two approaches, and results: Thoracic duct cannulation in small laboratory animalsMicrosurgery, 2003
- A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity.Journal of Experimental Medicine, 1991